
Original
Assessment of Drug Utilization Patterns of Supportive Therapy in Pediatric Patients with Acute Viral Hepatitis at a Tertiary Care Hospital
*Sattar S,1Quddush AR2
- *Dr. Shamima Sattar, Associate Professor, Department of Pharmacology and Therapeutics, Community Based Medical College, Bangladesh. shamimacbmcb@gmail.com. ORCID: https://orcid.org/0009-0006-3640-1721.
- Professor Dr. ASM. Ruhul Quddush, Professor & Head, Department of Pediatrics, Community Based Medical College and Hospital, Bangladesh. ORCID: https://orcid.org/0009-0005-8025-5912.
*For correspondence
Abstracts
Background: Acute viral hepatitis (AVH) remains a significant public health concern in pediatric populations, particularly in developing countries where inadequate sanitation and limited healthcare access facilitate the spread of hepatotropic viruses. Supportive therapy constitutes the mainstay of management; however, data on prescribing patterns in children are limited in Bangladesh.
Objective: To assess the drug utilization patterns of supportive therapy in pediatric patients with acute viral hepatitis admitted to Community Based Medical College Hospital, Bangladesh.
Methods:This descriptive observational study included 155 children aged <15 years with confirmed AVH, admitted between January 2024 to December 2024. The study was carried out through a collaborative effort between the Departments of Pediatrics and Pharmacology. Demographic data, viral etiology, clinical presentation, drug utilization for supportive therapy, length of hospital stay, and clinical outcomes were recorded. Supportive medications were categorized as oral rehydration solution (ORS), intravenous fluids, antiemetics, antipyretics, vitamin supplements, hepatoprotective agents, and antibiotics. Data were analysed using SPSS v26, and the association between antibiotic use and clinical outcomes was assessed using Chi-square or Fisher’s exact test, with p <0.05 considered statistically significant.
Results:The mean age of participants was 7.8 ± 3.4 years, with a male-to-female ratio of 1.35:1. Hepatitis A virus (HAV) was the most prevalent etiology 65.8%, followed by hepatitis E virus (HEV) 21.9%, while HBV and HCV were less common. Oral rehydration solution was administered to 80.0% of patients, antiemetics to 62.6%, antipyretics to 56.8%, intravenous fluids to 50.3%, vitamin supplements to 46.5%, hepatoprotective drugs to 34.8%, and antibiotics to 18.7%. The mean hospital stay was 6.4 ± 2.7 days. Clinical outcomes were favourable, with 72.3% fully recovered, 23.2% improved, and 4.5% experiencing complications. Antibiotic use was significantly associated with adverse outcomes (p = 0.041).
Conclusion: Hepatitis A virus is the predominant cause of pediatric AVH in Bangladesh, and supportive therapy remains the cornerstone of management. While overall prognosis is favourable, inappropriate antibiotic use was linked to adverse outcomes, emphasizing the need for rational prescribing. These findings highlight the importance of guideline-driven supportive care and provide insights into pediatric drug utilization patterns in resource-limited settings.
[Shaheed Syed Nazrul Islam Med Col J 2026, July; 11 (2):180-188]
DOI: https://www.doi.org/10.69699/ssnimcj.2026.11.2.11
Full PDF